ImmunoPrecise Antibodies (IPA) has released an update.
ImmunoPrecise Antibodies is set to host TECHDAY, showcasing its cutting-edge advancements in AI-driven drug discovery and biologics innovation. The event will feature presentations and demonstrations of their LENSai platform and B Cell Discovery Platform, highlighting the integration of artificial intelligence in accelerating therapeutic antibody design.
For further insights into IPA stock, check out TipRanks’ Stock Analysis page.
